Physician profile
Leroy Ekeh
NPI 1306467261
$3,275.63
in general payments reported to CMS, 2019-2025
8 companies · $978 in 2025
The $978 reported for 2025 was more than what 77% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $147 · 2022: $324 · 2023: $81.18 · 2024: $1,745 · 2025: $978.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,101 · Travel and Lodging: $703.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,101.18 |
| Travel and Lodging | $703.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $1,650.46 | 2023-2025 | Hydrus Microstent, Clareon, Centurion |
| Abbvie INC. | $432.87 | 2024-2025 | |
| Sight Sciences, INC. | $403.61 | 2024-2025 | Omni Surgical System |
| Rxsight INC | $136.47 | 2025 | Rxsight Injector Handpiece, Rxsight Contact Lens, Rxsight Light Delivery Device (Ldd) |
| Nova Eye, INC. | $111.80 | 2025 | |
| Apellis Pharmaceuticals, INC. | $28.00 | 2023 | |
| Ocular Therapeutix, INC. | $27.75 | 2025 | Dextenza |
| Amgen INC. | $13.62 | 2025 | Tepezza |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Leroy Ekeh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.